Irina Naguibneva

Irina Naguibneva

Auto-generated profile, based on publicly available information

Irina Naguibneva

Laboratoire des cellules Souches Hematopoietiques et des Leucemies, Equipe Niche et Cancer dans l'Hematopoiese, UMR1274-E008, INSERM, CEA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Stem Cell Reports
Verified
Journal Article
Open access
DDDounia Djeghloul
Dounia Djeghloul
KKKlaudia Kuranda
Klaudia Kuranda
IKIsabelle Kuzniak
Isabelle Kuzniak
DBDaniela Barbieri
Daniela Barbieri
INIrina Naguibneva
Irina Naguibneva
MGMichele Goodhardt
Michele Goodhardt
The capacity of hematopoietic stem cells (HSC) to generate B lymphocytes declines with age, contributing to impaired immune function in the elderly. Here we show that the histone methyltransferase SUV39H1 plays an important role in human B lymphoid differentiation and that expression of SUV39H1 decreases with age in both human and mouse HSC, leading to a global reduction in H3K9 trimethylation and perturbed heterochromatin function. Further, we demonstrate that SUV39H1 is a target of microRNA miR-125b, a known regulator of HSC function, and that expression of miR-125b increases with age in human HSC. Overexpression of miR-125b and inhibition of SUV39H1 in young HSC induced loss of B cell potential. Conversely, both inhibition of miR-125 and enforced expression of SUV39H1 improved the capacity of HSC from elderly individuals to generate B cells. Our findings highlight the importance of heterochromatin regulation in HSC aging and B lymphopoiesis.

4 May 2017 in Blood Advances
Verified
Journal Article
Open access
PDF file
LRLaurent Renou
Laurent Renou
PBPierre-Yves Boelle
Pierre-Yves Boelle
CDCaroline Deswarte
Caroline Deswarte
SSSalvatore Spicuglia
Salvatore Spicuglia
ABAissa Benyoucef
Aissa Benyoucef
INIrina Naguibneva
Irina Naguibneva
Key Points: TLX3 transactivates LINC00478, the host gene of oncogenic miR-125b-2 in T-ALL. TLX3 and miR-125b contribute to the differentiation arrest and the expansion of transformed T cells.

22 January 2021 in Blood Advances
Verified
Journal Article
Open access
PDF file
LFLucine Fahy
Lucine Fahy
JCJulien Calvo
Julien Calvo
SCSara Chabi
Sara Chabi
LRLaurent Renou
Laurent Renou
CMCharly Le Maout
Charly Le Maout
BUBenjamin Uzan
Benjamin Uzan
Resistance to chemotherapy, a major therapeutic challenge in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), can be driven by interactions between leukemic cells and the microenvironment that promote survival of leukemic cells. The bone marrow, an important leukemia niche, has low oxygen partial pressures that highly participate in the regulation of normal hematopoiesis. Here we show that hypoxia inhibits T-ALL cell growth by slowing down cell cycle progression, decreasing mitochondria activity, and increasing glycolysis, making them less sensitive to antileukemic drugs and preserving their ability to initiate leukemia after treatment. Activation of the mammalian target of rapamycin (mTOR) was diminished in hypoxic leukemic cells, and treatment of T-ALL with the mTOR inhibitor rapamycin in normoxia mimicked the hypoxia effects, namely decreased cell growth and increased quiescence and drug resistance. Knocking down (KD) hypoxia-induced factor 1α (HIF-1α), a key regulator of the cellular response to hypoxia, antagonized the effects observed in hypoxic T-ALL and restored chemosensitivity. HIF-1α KD also restored mTOR activation in low O2 concentrations, and inhibiting mTOR in HIF1α KD T-ALL protected leukemic cells from chemotherapy. Thus, hypoxic niches play a protective role of T-ALL during treatments. Inhibition of HIF-1α and activation of the mTORC1 pathway may help suppress the drug resistance of T-ALL in hypoxic niches.

7 April 2015 in Stem Cells
Verified
Journal Article
Open access
PDF file
ABAissa Benyoucef
Aissa Benyoucef
JCJulien Calvo
Julien Calvo
LRLaurent Renou
Laurent Renou
MAMarie-Laure Arcangeli
Marie-Laure Arcangeli
AHAnita van Den Heuvel
Anita van Den Heuvel
FPFrancoise Pflumio
Francoise Pflumio
Hematopoietic stem/progenitor cells (HSPCs) are regulated through numerous molecular mechanisms that have not been interconnected. The transcription factor stem cell leukemia/T-cell acute leukemia 1 (TAL1) controls human HSPC but its mechanism of action is not clarified. In this study, we show that knockdown (KD) or short-term conditional over-expression (OE) of TAL1 in human HSPC ex vivo, respectively, blocks and maintains hematopoietic potentials, affecting proliferation of human HSPC. Comparative gene expression analyses of TAL1/KD and TAL1/OE human HSPC revealed modifications of cell cycle regulators as well as previously described TAL1 target genes. Interestingly an inverse correlation between TAL1 and DNA damage-induced transcript 4 (DDiT4/REDD1), an inhibitor of the mammalian target of rapamycin (mTOR) pathway, is uncovered. Low phosphorylation levels of mTOR target proteins in TAL1/KD HSPC confirmed an interplay between mTOR pathway and TAL1 in correlation with TAL1-mediated effects of HSPC proliferation. Finally chromatin immunoprecipitation experiments performed in human HSPC showed that DDiT4 is a direct TAL1 target gene. Functional analyses showed that TAL1 represses DDiT4 expression in HSPCs. These results pinpoint DDiT4/REDD1 as a novel target gene regulated by TAL1 in human HSPC and establish for the first time a link between TAL1 and the mTOR pathway in human early hematopoietic cells. Stem Cells 2015;33:2268–2279

1 January 2007 in Biologie Aujourd'hui
Verified
Journal Article
Closed access
INIrina Naguibneva
Irina Naguibneva
APAnna Polesskaya
Anna Polesskaya
MAMaya Ameyar-Zazoua
Maya Ameyar-Zazoua
MSMouloud Souidi
Mouloud Souidi
RGReguina Groisman
Reguina Groisman
AHAnnick Harel-Bellan
Annick Harel-Bellan
Deciphering the mechanisms underlying skeletal muscle differentiation in mammals is an important challenge. Cell differentiation involves complex pathways regulated at both transcriptional and post-transcriptional levels. Recent observations have revealed the importance of small (20-25 base pairs) non-coding RNAs (microRNAs or miRNAs) that are expressed in both lower organisms and in mammals. miRNAs modulate gene expression by affecting mRNA translation or stability. In lower organisms, miRNAs are essential for cell differentiation during development; some miRNAs are involved in maintenance of the differentiated state. We have shown that miR-181, a microRNA that is strongly upregulated during differentiation, participates in establishing the muscle phenotype. Moreover, our results suggest that miR-181 downregulates the homeobox protein Hox-A11 (a repressor of the differentiation process), thus establishing a functional link between miR-181 and the complex process of mammalian skeletal muscle differentiation. Therefore, miRNAs can be involved in the establishment of a differentiated phenotype - even when they are not expressed in the corresponding fully differentiated tissue.

20 December 2007
Verified
Book Chapter
Closed access
INIrina Naguibneva
Irina Naguibneva
APAnna Polesskaya
Anna Polesskaya
AHAnnick Harel-Bellan
Annick Harel-Bellan